{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:07:59Z","timestamp":1793394479032,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pathogenic intestinal protozoa infections are common in school-aged children in the developing world and they are frequently associated with malabsorption syndromes and gastrointestinal morbidity. Since diagnosis of these parasites is difficult, prevalence data on intestinal protozoa is scarce.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We collected two stool samples from school-aged children on Pemba Island, Tanzania, as part of a randomized controlled trial before and 3 weeks after treatment with (i) single-dose albendazole (400 mg); (ii) single-dose nitazoxanide (1,000 mg); (iii) nitazoxanide-albendazole combination (1,000 mg\u2013400 mg), with each drug given separately on two consecutive days; and (iv) placebo. Formalin-fixed stool samples were examined for the presence of intestinal protozoa using an ether-concentration method to determine the prevalence and estimate cure rates (CRs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Almost half (48.7%) of the children were diagnosed with at least one of the (potentially) pathogenic protozoa <jats:italic>Giardia intestinalis<\/jats:italic>, <jats:italic>Entamoeba histolytica\/E. dispar<\/jats:italic> and <jats:italic>Blastocystis hominis.<\/jats:italic> Observed CRs were high for all treatment arms, including placebo. Nitazoxanide showed a significant effect compared to placebo against the non-pathogenic protozoon <jats:italic>Entamoeba coli.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Intestinal protozoa infections might be of substantial health relevance even in settings where they are not considered as a health problem. Examination of a single stool sample with the ether-concentration method lacks sensitivity for the diagnosis of intestinal protozoa, and hence, care is indicated when interpreting prevalence estimates and treatment effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-3305-6-3","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T15:14:39Z","timestamp":1357312479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole-nitazoxanide"],"prefix":"10.1186","volume":"6","author":[{"given":"Benjamin","family":"Speich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanspeter","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaali M","family":"Ame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac I","family":"Bogoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Utzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Albonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"key":"800_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/CMR.00033-10","volume":"24","author":"Y Feng","year":"2011","unstructured":"Feng Y, Xiao L: Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev. 2011, 24: 110-140. 10.1128\/CMR.00033-10.","journal-title":"Clin Microbiol Rev"},{"key":"800_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(03)12830-9","volume":"361","author":"SL Stanley","year":"2003","unstructured":"Stanley SL: Amoebiasis. Lancet. 2003, 361: 1025-1034. 10.1016\/S0140-6736(03)12830-9.","journal-title":"Lancet"},{"key":"800_CR3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380: 2095-2128. 10.1016\/S0140-6736(12)61728-0.","journal-title":"Lancet"},{"key":"800_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1517\/14656566.8.12.1885","volume":"8","author":"AA Escobedo","year":"2007","unstructured":"Escobedo AA, Cimerman S: Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother. 2007, 8: 1885-1902. 10.1517\/14656566.8.12.1885.","journal-title":"Expert Opin Pharmacother"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-12-391429-3.00007-1","volume":"77","author":"AR Jex","year":"2011","unstructured":"Jex AR, Smith HV, Nolan MJ, Campbell BE, Young ND, Cantacessi C, Gasser RB: Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies. Adv Parasitol. 2011, 77: 141-173.","journal-title":"Adv Parasitol"},{"key":"800_CR6","doi-asserted-by":"publisher","first-page":"b4168","DOI":"10.1136\/bmj.b4168","volume":"339","author":"AP Davies","year":"2009","unstructured":"Davies AP, Chalmers RM: Cryptosporidiosis. BMJ. 2009, 339: b4168-10.1136\/bmj.b4168.","journal-title":"BMJ"},{"key":"800_CR7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1017\/S0950268809002672","volume":"137","author":"CR Stensvold","year":"2009","unstructured":"Stensvold CR, Lewis HC, Hammerum AM, Porsbo LJ, Nielsen SS, Olsen KE, Arendrup MC, Nielsen HV, M\u00f8lbak K: Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect. 2009, 137: 1655-1663. 10.1017\/S0950268809002672.","journal-title":"Epidemiol Infect"},{"key":"800_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/j.1440-1746.2005.03868.x","volume":"20","author":"K Leder","year":"2005","unstructured":"Leder K, Hellard ME, Sinclair MI, Fairley CK, Wolfe R: No correlation between clinical symptoms and Blastocystis hominis in immunocompetent individuals. J Gastroenterol Hepatol. 2005, 20: 1390-1394. 10.1111\/j.1440-1746.2005.03868.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"800_CR9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/jcm.24.4.548-550.1986","volume":"24","author":"DJ Sheehan","year":"1986","unstructured":"Sheehan DJ, Raucher BG, McKitrick JC: Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol. 1986, 24: 548-550.","journal-title":"J Clin Microbiol"},{"key":"800_CR10","first-page":"15","volume":"59","author":"JS Yoder","year":"2010","unstructured":"Yoder JS, Harral C, Beach MJ: Giardiasis surveillance-United States, 2006\u20132008. MMWR Surveill Summ. 2010, 59: 15-25.","journal-title":"MMWR Surveill Summ"},{"key":"800_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1440-1746.2000.02089.x","volume":"15","author":"ME Hellard","year":"2000","unstructured":"Hellard ME, Sinclair MI, Hogg GG, Fairley CK: Prevalence of enteric pathogens among community based asymptomatic individuals. J Gastroenterol Hepatol. 2000, 15: 290-293. 10.1046\/j.1440-1746.2000.02089.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.1988.03410090077034","volume":"260","author":"DN Taylor","year":"1988","unstructured":"Taylor DN, Houston R, Shlim DR, Bhaibulaya M, Ungar BL, Echeverria P: Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA. 1988, 260: 1245-1248. 10.1001\/jama.1988.03410090077034.","journal-title":"JAMA"},{"key":"800_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/adc.2008.151852","volume":"94","author":"AA Escobedo","year":"2009","unstructured":"Escobedo AA, Almirall P, Alfonso M, Cimerman S, Rey S, Terry SL: Treatment of intestinal protozoan infections in children. Arch Dis Child. 2009, 94: 478-482. 10.1136\/adc.2008.151852.","journal-title":"Arch Dis Child"},{"key":"800_CR14","first-page":"122","volume":"64","author":"R Rodriguez-Garcia","year":"1999","unstructured":"Rodriguez-Garcia R, Rodriguez-Guzman LM, Cruz del Castillo AH: Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children. Rev Gastroenterol Mex. 1999, 64: 122-126.","journal-title":"Rev Gastroenterol Mex"},{"key":"800_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1198-743X.2004.00829.x","volume":"10","author":"K Yereli","year":"2004","unstructured":"Yereli K, Balcioglu IC, Ertan P, Limoncu E, Onag A: Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. Clin Microbiol Infect. 2004, 10: 527-529. 10.1111\/j.1198-743X.2004.00829.x.","journal-title":"Clin Microbiol Infect"},{"key":"800_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1046\/j.1365-2036.2001.01066.x","volume":"15","author":"JJ Ortiz","year":"2001","unstructured":"Ortiz JJ, Ayoub A, Gargala G, Chegne NL, Favennec L: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru. Aliment Pharmacol Ther. 2001, 15: 1409-1415. 10.1046\/j.1365-2036.2001.01066.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"800_CR17","first-page":"27","volume":"29","author":"S Pampiglione","year":"1987","unstructured":"Pampiglione S, Visconti S, Stefanini A: Human intestinal parasites in sub-Saharan Africa. III. Pemba Island (Zanzibar-Tanzania). Parassitologia. 1987, 29: 27-35. in Italian","journal-title":"Parassitologia"},{"key":"800_CR18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/00034983.1993.11812813","volume":"87","author":"M Albonico","year":"1993","unstructured":"Albonico M, De Carneri I, Di Matteo L, Ghiglietti R, Toscano P, Uledi MK, Savioli L: Intestinal parasitic infections of urban and rural children on Pemba Island: implications for control. Ann Trop Med Parasitol. 1993, 87: 579-583.","journal-title":"Ann Trop Med Parasitol"},{"key":"800_CR19","doi-asserted-by":"publisher","first-page":"e1685","DOI":"10.1371\/journal.pntd.0001685","volume":"6","author":"B Speich","year":"2012","unstructured":"Speich B, Ame SM, Ali SM, Alles R, Hattendorf J, Utzinger J, Albonico M, Keiser J: Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial. PLoS Negl Trop Dis. 2012, 6: e1685-10.1371\/journal.pntd.0001685.","journal-title":"PLoS Negl Trop Dis"},{"key":"800_CR20","first-page":"1473","volume":"120","author":"H Marti","year":"1990","unstructured":"Marti H, Escher E: SAF-an alternative fixation solution for parasitological stool specimens. Schweiz Med Wochenschr. 1990, 120: 1473-1476. in German","journal-title":"Schweiz Med Wochenschr"},{"key":"800_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1469-0691.2009.02782.x","volume":"16","author":"J Utzinger","year":"2010","unstructured":"Utzinger J, Botero-Kleiven S, Castelli F, Chiodini PL, Edwards H, Kohler N, Gulletta M, Lebbad M, Manser M, Matthys B: Microscopic diagnosis of sodium acetate-acetic acid-formalin-fixed stool samples for helminths and intestinal protozoa: a comparison among European reference laboratories. Clin Microbiol Infect. 2010, 16: 267-273. 10.1111\/j.1469-0691.2009.02782.x.","journal-title":"Clin Microbiol Infect"},{"key":"800_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1550-7408.1993.tb04926.x","volume":"40","author":"LS Diamond","year":"1993","unstructured":"Diamond LS, Clark CG: A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol. 1993, 40: 340-344. 10.1111\/j.1550-7408.1993.tb04926.x.","journal-title":"J Eukaryot Microbiol"},{"key":"800_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MOG.0b013e32831da7dd","volume":"25","author":"KK Pierce","year":"2009","unstructured":"Pierce KK, Kirkpatrick BD: Update on human infections caused by intestinal protozoa. Curr Opin Gastroenterol. 2009, 25: 12-17. 10.1097\/MOG.0b013e32831da7dd.","journal-title":"Curr Opin Gastroenterol"},{"key":"800_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1674-8301(11)60001-8","volume":"25","author":"GJ Leitch","year":"2012","unstructured":"Leitch GJ, He Q: Cryptosporidiosis-an overview. J Biomed Res. 2012, 25: 1-16. 10.1016\/S1674-8301(11)60001-8.","journal-title":"J Biomed Res"},{"key":"800_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1756-3305-5-135","volume":"5","author":"JT Coulibaly","year":"2012","unstructured":"Coulibaly JT, F\u00fcrst T, Silu\u00e9 KD, Knopp S, Hauri D, Ouattara M, Utzinger J, N\u2019Goran EK: Intestinal parasitic infections in schoolchildren in different settings of C\u00f4te d\u2019Ivoire: effect of diagnostic approach and implications for control. Parasit Vectors. 2012, 5: 135-10.1186\/1756-3305-5-135.","journal-title":"Parasit Vectors"},{"key":"800_CR26","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/jcm.31.11.3044-3045.1993","volume":"31","author":"H Marti","year":"1993","unstructured":"Marti H, Koella JC: Multiple stool examinations for ova and parasites and rate of false-negative results. J Clin Microbiol. 1993, 31: 3044-3045.","journal-title":"J Clin Microbiol"},{"key":"800_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/QCO.0b013e32833de0eb","volume":"23","author":"L van Lieshout","year":"2010","unstructured":"van Lieshout L, Verweij JJ: Newer diagnostic approaches to intestinal protozoa. Curr Opin Infect Dis. 2010, 23: 488-493. 10.1097\/QCO.0b013e32833de0eb.","journal-title":"Curr Opin Infect Dis"},{"key":"800_CR28","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1128\/JCM.01035-10","volume":"49","author":"SL Becker","year":"2011","unstructured":"Becker SL, Lohourignon LK, Speich B, Rinaldi L, Knopp S, N\u2019Goran EK, Cringoli G, Utzinger J: Comparison of the Flotac-400 dual technique and the formalin-ether concentration technique for diagnosis of human intestinal protozoon infection. J Clin Microbiol. 2011, 49: 2183-2190. 10.1128\/JCM.01035-10.","journal-title":"J Clin Microbiol"},{"key":"800_CR29","first-page":"941","volume":"35","author":"HZE Rayan","year":"2005","unstructured":"Rayan HZE: Microscopic overdiagnosis of intestinal amoebiasis. J Egypt Soc Parasitol. 2005, 35: 941-951.","journal-title":"J Egypt Soc Parasitol"},{"key":"800_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.actatropica.2009.06.012","volume":"112","author":"AK Mohammed Mahdy","year":"2009","unstructured":"Mohammed Mahdy AK, Surin J, Wan KL, Mohd-Adnan A, Hesham Al-Mekhlafi MS, Lim YAL: Giardia intestinalis genotypes: risk factors and correlation with clinical symptoms. Acta Trop. 2009, 112: 67-70. 10.1016\/j.actatropica.2009.06.012.","journal-title":"Acta Trop"},{"key":"800_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1756-3305-4-96","volume":"4","author":"SG Traor\u00e9","year":"2011","unstructured":"Traor\u00e9 SG, Odermatt P, Bonfoh B, Utzinger J, Aka ND, Adoubryn KD, Assoumou A, Dreyfuss G, Kouss\u00e9mon M: No Paragonimus in high-risk groups in C\u00f4te d'Ivoire, but considerable prevalence of helminths and intestinal protozoon infections. Parasit Vectors. 2011, 4: 96-10.1186\/1756-3305-4-96.","journal-title":"Parasit Vectors"},{"key":"800_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4269\/ajtmh.2004.71.65","volume":"71","author":"E Cifuentes","year":"2004","unstructured":"Cifuentes E, Suarez L, Espinosa M, Juarez-Figueroa L, Martinez-Palomo A: Risk of Giardia intestinalis infection in children from an artificially recharged groundwater area in Mexico City. Am J Trop Med Hyg. 2004, 71: 65-70.","journal-title":"Am J Trop Med Hyg"},{"key":"800_CR33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S0950268803001018","volume":"131","author":"MS Prado","year":"2003","unstructured":"Prado MS, Strina A, Barreto ML, Oliveira-Assis AM, Paz LM, Cairncross S: Risk factors for infection with Giardia duodenalis in pre-school children in the city of Salvador, Brazil. Epidemiol Infect. 2003, 131: 899-906. 10.1017\/S0950268803001018.","journal-title":"Epidemiol Infect"},{"key":"800_CR34","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1371\/journal.pntd.0000682","volume":"4","author":"S Solaymani-Mohammadi","year":"2010","unstructured":"Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM: A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis. 2010, 4: e682-10.1371\/journal.pntd.0000682.","journal-title":"PLoS Negl Trop Dis"},{"key":"800_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.idc.2012.03.009","volume":"26","author":"SG Wright","year":"2012","unstructured":"Wright SG: Protozoan infections of the gastrointestinal tract. Infect Dis Clin North Am. 2012, 26: 323-339. 10.1016\/j.idc.2012.03.009.","journal-title":"Infect Dis Clin North Am"},{"key":"800_CR36","first-page":"209","volume":"59","author":"RC Rendtorff","year":"1954","unstructured":"Rendtorff RC: The experimental transmission of human intestinal protozoan parasites. II. Giardia lambliacysts given in capsules. Am J Hyg. 1954, 59: 209-220.","journal-title":"Am J Hyg"},{"key":"800_CR37","first-page":"327","volume":"60","author":"RC Rendtorff","year":"1954","unstructured":"Rendtorff RC, Holt CJ: The experimental transmission of human intestinal protozoan parasites. IV. Attempts to transmitEndamoeba coliandGiardia lambliacysts by water. Am J Hyg. 1954, 60: 327-338.","journal-title":"Am J Hyg"},{"key":"800_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0140-6736(85)90412-X","volume":"326","author":"AM Jokipii","year":"1985","unstructured":"Jokipii AM, Hemil\u00e4 M, Jokipii L: Prospective study of acquisition of Cryptosporidium, Giardia lamblia, and gastrointestinal illness. Lancet. 1985, 326: 487-489. 10.1016\/S0140-6736(85)90412-X.","journal-title":"Lancet"},{"key":"800_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-0327-5","volume-title":"Parasitic Diseases","author":"M Katz","year":"1989","unstructured":"Katz M, Despammier DD, Gwadz RW: Parasitic Diseases. 1989, New York, N.Y: Springer"},{"key":"800_CR40","volume-title":"Diagnostic Medical Parasitology","author":"LS Garcia","year":"1997","unstructured":"Garcia LS, Bruckner DA: Diagnostic Medical Parasitology. 1997, Washington, D.C.: ASM Press, 3","edition":"3"},{"key":"800_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1086\/320894","volume":"33","author":"PC Okhuysen","year":"2001","unstructured":"Okhuysen PC: Traveler\u2019s diarrhea due to intestinal protozoa. Clin Infect Dis. 2001, 33: 110-114. 10.1086\/320894.","journal-title":"Clin Infect Dis"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-3305-6-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:54:15Z","timestamp":1630540455000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/1756-3305-6-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1186\/1756-3305-6-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]},"assertion":[{"value":"13 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}